(Q48671400)

14 February 2018

title

Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. (English)

1 reference

14 February 2018

author name string

D W Sturdee

1

1 reference

14 February 2018

A Pines

2

1 reference

14 February 2018

International Menopause Society Writing Group

3

1 reference

14 February 2018

D F Archer

4

1 reference

14 February 2018

R J Baber

5

1 reference

14 February 2018

D Barlow

6

1 reference

14 February 2018

M H Birkhäuser

7

1 reference

14 February 2018

M Brincat

8

1 reference

14 February 2018

L Cardozo

9

1 reference

14 February 2018

T J de Villiers

10

1 reference

14 February 2018

M Gambacciani

11

1 reference

14 February 2018

A A Gompel

12

1 reference

14 February 2018

V W Henderson

13

1 reference

14 February 2018

C Kluft

14

1 reference

14 February 2018

R A Lobo

15

1 reference

14 February 2018

A H MacLennan

16

1 reference

14 February 2018

J Marsden

17

1 reference

14 February 2018

R E Nappi

18

1 reference

14 February 2018

N Panay

19

1 reference

14 February 2018

J H Pickar

20

1 reference

14 February 2018

D Robinson

21

1 reference

14 February 2018

J Simon

22

1 reference

14 February 2018

R L Sitruk-Ware

23

1 reference

14 February 2018

J C Stevenson

24

1 reference

14 February 2018

publication date

1 June 2011

1 reference

14 February 2018

published in

Climacteric

1 reference

14 February 2018

volume

14

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

page(s)

302-320

1 reference

14 February 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

KEEPS: The Kronos Early Estrogen Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Vigorous Leisure Activity through Women's Adult Life: The Women's Health Initiative Observational Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Exercise for health for early postmenopausal women: a systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Diet and lifestyle in managing postmenopausal obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

The association between physical activity and osteoporotic fractures: a review of the evidence and implications for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Smoking and smoking cessation in relation to mortality in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Physical activity and risk of breast cancer among postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

State of the epidemiological evidence on physical activity and cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Risk factors for mortality in the nurses' health study: a competing risks analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of estrogen with and without progestin on urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Oestrogen therapy for urinary incontinence in post-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Postmenopausal osteoporosis: therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Management of osteoporosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Preventing osteoporosis in symptomatic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

HRT, osteoporosis and regulatory authorities Quis custodiet ipsos custodes?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

The effects of tibolone in older postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Calcium plus vitamin D supplementation and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Raloxifene use in clinical practice: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Ethnic differences in levels of bone and cartilage biomarkers and hormonal responsiveness in nine groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Coronary heart disease and menopause management: the swinging pendulum of HRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

A clinical trial of estrogen-replacement therapy after ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Association between hormone replacement therapy and subsequent stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Hormone therapy and cerebrovascular events: a population-based nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Transdermal hormone therapy and the risk of stroke and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of combination estrogen plus progestin hormone treatment on cognition and affect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of the menopause transition and hormone use on cognitive performance in midlife women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Action of estrogens in the aging brain: dementia and cognitive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Gonadal hormones and cognitive aging: a midlife perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Timing of hormone therapy and dementia: the critical window theory revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Associations of hormones and menopausal status with depressed mood in women with no history of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Symptoms in the menopausal transition: hormone and behavioral correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Estrogen replacement and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Hormone therapy and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Menopause and aging, quality of life and sexuality.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Risk factors for female sexual dysfunction in the general population: exploring factors associated with low sexual function and sexual distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

The use of estrogen therapy in women's sexual functioning (CME).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Androgen levels in adult females: changes with age, menopause, and oophorectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Testosterone for low libido in postmenopausal women not taking estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Testosterone treatment of HSDD in naturally menopausal women: the ADORE study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

DHEA for postmenopausal women: a review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Bioidentical hormone therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

The 'bioidentical/bioequivalent' hormone scam.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Bioidentical hormones for menopausal hormone therapy: variation on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Bioidentical hormones for menopausal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Recommendations for the management of postmenopausal vaginal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Efficacy and tolerability of local estrogen therapy for urogenital atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Endometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Hormone replacement therapy: real concerns and false alarms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.570590

10.3109/13697137.2011.570590

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018